CALC earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.56. Updated 2026-07-23.
CalciMedica (CALC) Research Hub
CalciMedica (CALC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.98 USD (-13.91%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.56, market cap 0.01B. This hub links to the full technical, earnings and options research available for CALC.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.98 USD (-13.91%) |
| 52-week range | 1.91 USD – 5.45 USD |
| Trend regime | Range |
| 14-day RSI | 22.1 (Oversold) |
| Trailing P/E | -0.56 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for CALC
Covered Call on CALC: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CALC: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CALC: how it works, illustrative setup around the real 1.98 USD price, max profit/loss, breakeven and when to use it. Educational.
CALC technical analysis: range, last 1.98 USD, RSI 22.1, 52w range 1.91 USD–5.45 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CALC in?
CalciMedica (CALC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CALC in an uptrend or downtrend?
As of 2026-09-11, CALC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CALC's trailing P/E ratio?
CALC's trailing P/E is -0.56, with a market cap of 0.01B. See the earnings research page for full valuation detail.